Project 1. Entitled: Aviator Group A Strep study.
The Aviator research study which commenced in October 2023 has made significant progress which has inspired the investigators in the Spencer Dayman Meningitis Laboratories at the University of Bristol to successfully apply for another 2 years funding.
The project will now continue until October 2027. Group A Strep is one of the biggest causes of sepsis in addition to a number of other life-threatening diseases including meningitis and heart disease. The aim of the project is to provide evidence towards the development and introduction of a Group A Streptococcal vaccine.
This brings our total commitment to this project to over £154,000.
